​

Cytek Biosciences (CTKB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Cytek Biosciences Revenue Highlights

Latest Revenue (Y)

$193.01M

Latest Revenue (Q)

$51.50M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Cytek Biosciences Revenue by Period

Cytek Biosciences Revenue by Year

DateRevenueChange
2023-12-31$193.01M17.67%
2022-12-31$164.04M28.20%
2021-12-31$127.95M37.82%
2020-12-31$92.84M60.39%
2019-12-31$57.88M-

Cytek Biosciences generated $193.01M in revenue during NA 2023, up 17.67% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Cytek Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30$51.50M10.47%
2024-06-30$46.62M3.92%
2024-03-31$44.86M-22.96%
2023-12-31$58.23M21.32%
2023-09-30$48.00M-3.41%
2023-06-30$49.69M33.99%
2023-03-31$37.09M-23.27%
2022-12-31$48.34M19.42%
2022-09-30$40.48M0.79%
2022-06-30$40.16M14.53%
2022-03-31$35.06M-9.85%
2021-12-31$38.89M13.14%
2021-09-30$34.38M13.05%
2021-06-30$30.41M25.28%
2021-03-31$24.27M-20.73%
2020-12-31$30.62M22.01%
2020-09-30$25.10M31.15%
2020-06-30$19.14M6.38%
2020-03-31$17.99M-

Cytek Biosciences generated $51.50M in revenue during Q3 2024, up 10.47% compared to the previous quarter, and up 103.64% compared to the same period a year ago.

Cytek Biosciences Revenue Breakdown

Cytek Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Service$36.49M$15.44M$8.43M
Product$156.72M$148.60M$119.52M

Cytek Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (81.11%), and Service (18.89%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Service$39.00M$36.87M-$37.00M$9.24M$5.92M$4.70M$4.09M$3.07M$3.58M$2.94M$2.19M$1.73M
Product$39.54M$34.12M$46.65M$38.44M$40.45M$31.17M$43.64M$36.39M$37.09M$31.48M$35.95M$32.19M$28.68M

Cytek Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (50.35%), and Service (49.65%).

Cytek Biosciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
Asia Pacific$31.60M$22.52M$16.08M
EMEA$53.18M$43.96M$36.97M
Other$6.15M$2.96M$2.18M
UNITED STATES$102.08M$94.59M$72.72M

Cytek Biosciences's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (52.89%), EMEA (27.55%), Asia Pacific (16.37%), and Other (3.19%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Other$979.00K$2.02M$1.51M$1.53M$2.12M$996.00K$1.29M$212.00K$418.00K$1.04M$633.00K$1.42M$111.00K
EMEA$17.23M$15.13M$21.14M$12.92M$9.08M$10.03M$16.14M$10.30M$8.84M$8.68M$13.48M$6.18M-
Asia Pacific$8.94M$6.35M$11.57M$6.76M$7.05M$6.22M$4.22M$7.15M$6.14M$5.01M$6.63M$2.80M$3.39M
UNITED STATES$24.35M$21.36M$24.02M$26.79M$31.44M$19.84M$26.70M$22.81M$24.76M$20.32M$18.14M$23.98M$17.25M
E M E A------------$9.66M

Cytek Biosciences's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (47.29%), EMEA (33.46%), Asia Pacific (17.35%), and Other (1.90%).

Cytek Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LIVNLivaNova$1.15B$318.11M
INGNInogen$315.66M$88.83M
CTKBCytek Biosciences$193.01M$51.50M
AXGNAxoGen$159.01M$48.64M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$126.08M$30.34M
RXSTRxSight$89.08M$45.41M
SGHTSight Sciences$81.06M$20.16M
LUNGPulmonx$68.67M$20.39M
NPCENeuroPace$65.42M$21.06M
APYXApyx Medical$52.35M$16.02M
SSKNSTRATA Skin Sciences$33.36M$8.44M
OFIXOrthofix Medical$100.00K$198.62M

CTKB Revenue FAQ

What is Cytek Biosciences’s yearly revenue?

Cytek Biosciences's yearly revenue for 2023 was $193.02M, representing an increase of 17.67% compared to 2022. The company's yearly revenue for 2022 was $164.04M, representing an increase of 28.20% compared to 2021. CTKB's yearly revenue for 2021 was $127.95M, representing an increase of 37.82% compared to 2020.

What is Cytek Biosciences’s quarterly revenue?

Cytek Biosciences's quarterly revenue for Q3 2024 was $51.5M, a 10.47% increase from the previous quarter (Q2 2024), and a 7.29% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $46.62M, a 3.92% increase from the previous quarter (Q1 2024), and a -6.19% decrease year-over-year (Q2 2023). CTKB's quarterly revenue for Q1 2024 was $44.86M, a -22.96% decrease from the previous quarter (Q4 2023), and a 20.96% increase year-over-year (Q1 2023).

What is Cytek Biosciences’s revenue growth rate?

Cytek Biosciences's revenue growth rate for the last 3 years (2021-2023) was 50.85%, and for the last 5 years (2019-2023) was 233.46%.

What are Cytek Biosciences’s revenue streams?

Cytek Biosciences's revenue streams in c 23 are Service, and Product. Service generated $36.49M in revenue, accounting 18.89% of the company's total revenue, up 136.40% year-over-year. Product generated $156.72M in revenue, accounting 81.11% of the company's total revenue, up 5.46% year-over-year.

What is Cytek Biosciences’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Cytek Biosciences was Product. This segment made a revenue of $156.72M, representing 81.11% of the company's total revenue.